1.
Wazir N, Rehman SU. Efficacy and Safety of Empagliflozin as Add-On Therapy in Patients of Type-2 Diabetes Mellitus. J Gandhara Med Dent Sci [Internet]. 2022 Jan. 7 [cited 2024 Sep. 18];9(1):24-7. Available from: http://jgmds.org.pk/index.php/JGMDS/article/view/173